Home >
Publications/Products > HIV/Hepatitis C Coinfection Guidelines
for Health Care Providers
Table 4. Hepatic Disease in HIV by Range of CD4 Lymphocyte Count
Back to Management and Treatment of Hepatitis C Virus Infection in HIV-Infected Adults
| CD4<500 | CD4<200 | CD4<100 |
|---|---|---|
| Predominantly cholestatic | ||
| Drug Toxicity | Fungal Infection | Cytomegalovirus |
| Tuberculosis | Candidiasis | Mycobacterium avium complex (MAC) |
| Kaposi's sarcoma | Coccidioidomycosis | Microsporidia |
| Lymphoma | Histoplasmosis | |
| Cholelithiasis | Cryptococcosis | |
| Acalculous cholecystitis | Blastomycosis | |
| Bacterial abscess | Cryptosporidia | |
| AIDS cholangiopathy | ||
| Bacillary angiomatosis and peliosis due to bartonella infection | ||
| Predominantly hepatocellular | ||
| Drug toxicity | Pneumocystis carinii | Cytomegalovirus |
| Steatosis | ||
| Viral hepatitis | ||
| Herpes simplex virus | ||
From Management and Treatment of Hepatitis C Virus Infection in HIV-Infected Adults
Hepatitis C Resource Center Program and National Hepatitis C Program Office
September 2005
